Wellington Management Group
CORT icon

Wellington Management Group’s Corcept Therapeutics CORT Stock Holding History

Wellington Management Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,534
Closed -$2.46M – 1996
2025
Q2 		$2.46M Sell
33,534
-1,976
-6% -$143K ﹤0.01% 1529
2025
Q1 		$4.06M Sell
35,510
-2,209
-6% -$134K ﹤0.01% 1410
2024
Q4 		$1.9M Sell
37,719
-3,347
-8% -$175K ﹤0.01% 1579
2024
Q3 		$1.9M Sell
41,066
-4,195
-9% -$149K ﹤0.01% 1553
2024
Q2 		$1.47M Sell
45,261
-2,529
-5% -$69.3K ﹤0.01% 1583
2024
Q1 		$1.2M Buy
47,790
+7,405
+18% +$175K ﹤0.01% 1639
2023
Q4 		$1.31M Buy
+40,385
New +$1.11M ﹤0.01% 1572
2023
Q1 		– Sell
-37,015
Closed -$752K – 2014
2022
Q4 		$752K Buy
37,015
+28,706
+345% +$720K ﹤0.01% 1711
2022
Q3 		$213K Buy
+8,309
New +$222K ﹤0.01% 1966
2021
Q4 		– Sell
-25,899
Closed -$510K – 2197
2021
Q3 		$510K Buy
+25,899
New +$542K ﹤0.01% 1929
2020
Q3 		– Sell
-30,170
Closed -$507K – 1897
2020
Q2 		$507K Sell
30,170
-72,039
-70% -$1.01M ﹤0.01% 1646
2020
Q1 		$1.22M Sell
102,209
-97,419
-49% -$1.21M ﹤0.01% 1482
2019
Q4 		$2.42M Buy
+199,628
New +$2.78M ﹤0.01% 1509
2019
Q2 		– Sell
-44,926
Closed -$527K – 2063
2019
Q1 		$527K Buy
+44,926
New +$558K ﹤0.01% 1893
2018
Q3 		– Sell
-34,125
Closed -$536K – 2222
2018
Q2 		$536K Sell
34,125
-134,925
-80% -$2.35M ﹤0.01% 2024
2018
Q1 		$2.78M Sell
169,050
-190,095
-53% -$3.52M ﹤0.01% 1649
2017
Q4 		$6.49M Sell
359,145
-4,218
-1% -$76.4K ﹤0.01% 1399
2017
Q3 		$7.01M Buy
363,363
+101,430
+39% +$1.51M ﹤0.01% 1379
2017
Q2 		$3.09M Buy
261,933
+139,985
+115% +$1.52M ﹤0.01% 1581
2017
Q1 		$1.34M Buy
121,948
+51,597
+73% +$453K ﹤0.01% 1846
2016
Q4 		$511K Buy
+70,351
New +$551K ﹤0.01% 2002

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Wellington Management Group's CORT Position: Q3 2025 in Review

Wellington Management Group sold out of Corcept Therapeutics (CORT) in Q3 2025, closing a stake of 33,534 shares — an estimated $2.46M sold.

Wellington Management Group first reported a position in CORT in Q4 2016 and held it in 21 quarters. The position peaked at $7.01M in Q3 2017. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Wellington Management Group reported no remaining Corcept Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 33,534 Corcept Therapeutics shares in Q3 2025, an estimated $2.46M.
  • Wellington Management Group first reported a position in Corcept Therapeutics in Q4 2016 and held it in 21 quarters.
  • Wellington Management Group's Corcept Therapeutics position peaked at $7.01M in Q3 2017.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.